# ACETAMINOPHEN, ASPIRIN AND CAFFEINE
> **ANDA211695** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-02-02
## Drug
- **FDA Application Number:** ANDA211695
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- **Generic name:** ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- **Active ingredients:** ACETAMINOPHEN; ASPIRIN; CAFFEINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Amazon.com Services LLC
- **First approval:** 2022-02-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211695)
---
*AI Analytics · CC0 1.0*